2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow AC: new trials by email Literature Review of AC trials Research Report on AC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety and Efficacy of Ipatasertib in Combination With Atezolizumab and Paclitaxel or Nab-Paclitaxel in Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer Ipatasertib, Paclitaxel, Atezolizumab - Breast Cancer | Phase 1 | Completed | Hoffmann-La Roche | 139 | 2018-02-13 | 2024-10-30 |
| Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment Azacitidine Injection, sodium phenylbutyrate - Lymphoma, Small Intestine Cancer | Phase 1 | Completed | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 34 | 2000-03-01 | 2019-01-11 |
Breast Neoplasms (1) · Burkitt Lymphoma (1) · Hodgkin Disease (1) · Immunoblastic Lymphadenopathy (1) · Intraocular Lymphoma (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma (1) · Lymphoma, B-Cell, Marginal Zone (1) · Lymphoma, Follicular (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Large-Cell, Anaplastic (1) · Lymphoma, Large-Cell, Immunoblastic (1) · Lymphoma, Mantle-Cell (1) · Lymphoma, Non-Hodgkin (1) · Lymphoma, T-Cell, Cutaneous (1)
Hoffmann-La Roche (1) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)
United States (2) · Australia (1) · France (1) · Spain (1) · United Kingdom (1)
2017 (1), P30CA006973 (1), P50CA058236 (1), R01CA075525 (1), U01CA070095 (1)